Aurora Therapeutics
Aurora Therapeutics is a CRISPR gene-editing biotechnology company based in Cambridge, Massachusetts, developing scalable, personalized genetic medicines for rare diseases. Founded by gene-editing pioneers including Nobel laureate Jennifer Doudna and Fyodor Urnov and led by CEO Edward M. Kaye, the company uses an "umbrella" approach that bundles multiple rare disease-causing mutations under a single regulatory pathway, combining guide RNA design, AI-engineered editors, and delivery systems to correct mutations at scale. Backed by Menlo Ventures, Aurora is profiled in the API Evangelist network; as of this pass it publishes a corporate website and news surface but no public API, developer portal, SDK, or other technical/developer surface.
Aurora Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Gene Editing, CRISPR, and Rare Disease.
Aurora Therapeutics’ developer surface includes product news and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 4
The organization behind the API